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A new look at CardiolipinIn 1947 cardiolipin (CL) became the ﬁrst-characterized phospho-
lipid [1]. Mary Pangborn named it cardiolipin because she had isolated
it from beef heart. Although ﬁrst to be characterized it was the last of
the major phospholipids to be stereochemically described [2] and
synthesized, in 1966 [3]. In 1972 its biosynthesis in Escherichia coli
and mitochondria were established [4,5]. That was the era when
knowledge of lipid structures and metabolism were emerging largely
due to the efforts of Laurens van Deenen in Utrecht. van Deenen was
also the Editor of Biochimica et Biophysica Acta and nurtured it
through the period of its greatest growth.
In 1998, Hoch published the most recent comprehensive review of
CL in all its known roles [6]. There are several recent specialized
reviews on cardiolipin [7–9]. However, the Hoch review represents a
break in the cardiolipin story because in 1996 it was recognized that
the defective gene in Barth’s syndrome was the taffazin gene [10]. A
ﬂurry of research on cardiolipin resulted from that discovery. There
had not previously been a disease related to CL. Barth’s syndrome
(BTHS) [11] is a sex-linked recessive disorder, clinically characterized
by the classical symptoms cardio-myopathy, neutropenia and delayed
growth with a lethal effect on small boys. The product of the taffazin
gene modiﬁes the structure of CL by transacylation, the exchange of
fatty acids. That was also unexpected since there had rarely been a
reason to think that phospholipid chains were speciﬁc to a particular
phospholipid.
Textbooks display CL’s structure and then stop there, as neither its
function nor its conformation had been proposed. I list here the most
important facts known about it for decades:
CL occurs primarily in membranes that also contain the F0F1-
ATPase. In eukaryotes it is the only phospholipid that is synthesized in
the mitochondrion, where it remains until the cell dies. All other
phospholipids are synthesized in the endoplasmic reticulum. CL has
high binding afﬁnity for each of the membrane proteins that are
involved in the synthesis of ATP in the mitochondrion. This includes
cytochrome oxidase [12,13], the ATP/ADP exchange protein [14], the
F0F1 ATP synthase [15], the orthophosphate transporter [16], and its
association with the cytochrome bc1 complex [17]. Most prokaryotes
contain the F0F1 ATP synthase and CL in their plasma membrane
constitutively. Some prokaryotes only contain the F0F1 ATP synthase
and CL during oxidative phosphorylation and yet anaerobically lack
both. These prokaryotes include the photosynthetic bacteria and
archaea as described by Corcelli [18]. This evidence suggests CL plays
an important role in the bioenergetics of the cell, most likely in ATP
synthesis itself. Failure of ATP synthesis appears as a possible
explanation of the genetic disease associated with CL in BTHS [19].
Also related to bioenergetics, cardiolipin plays a central role in the
destruction of the mitochondrion as the energy center of the cell
during apoptosis [20].
Recent research has identiﬁed other specialty roles for cardiolipin
metabolism, cell biology and physiology. Each of these has been0005-2736/$ – see front matter © 2009 Published by Elsevier B.V.
doi:10.1016/j.bbamem.2009.09.008covered here. Osmoregulation in E. coli [21], fatty acid transport in
human kidney cells [22], mitochondrial carriers [23,24], mitochon-
drial kinases [25], the organization of mitochondrial and prokaryote
membranes [26,27] and bilayers [28], and its biosynthesis [29]. These
subjects are all covered here.
1. Recent Insights into cardiolipin's structure
CL has a high pK2 (N7.0) based on a titration (Fig. 1). This has
changed our understanding of its conformation in bilayers [30,31]. In
1960, Pangborn sent a sample of her original phospholipid prepara-
tion to A. V. Few at Cambridge who measured its pK’s by
microelectrophoresis [32]. It displayed the expected low pK1 (1.04),
but as the titration continued Few found a high peak of unknown
origin which he declared was an artifact since it had not occurred in
any of his other membrane samples. This rise stimulated a renewed
search for a second pK by Kates et al. [30]. The titration curve they
obtained (Fig. 1) was similar to that observed by Few. The pK2 turned
out to be N8.0 as measured by the consumption of 2 equivalents of
base. To test the conformation in Fig. 2 Kates synthesized dCL, which
lacks the free OH on the connecting glycerol. The dCL titration (Fig. 1)
showed that the measured high (N8.0) pK2 is indeed due to the
presence of the free hydroxyl. These experiments required that the
headgroup is stabilized by two high-energy H-bonds of the phos-
phates on that free hydroxyl group (Fig. 2). In order to create the
bicyclic headgroup conformation, one phosphate must pick up a
proton from solution. The headgroup thus has a single electron
delocalized between the 2 phosphates.
Until these experiments, CL’s 2 pK’s, had not been observed
because they had not been measured in bilayers. In solution or as a
powder, FTIR experiments show CL to have a different conformation
in the phosphate region than it has in bilayers (T. H. Haines, H. Deng
and R. Callender, unpublished). Thus the conformation shown in Fig. 2
only applies to the lipid in bilayers. Furthermore the titration curve for
CL in bilayers is unusual with respect to its pK2. A computer
simulation [30] did not match a single pK2 in the range from 6.0 to
8.0. The simulation showed that the pK2 drifts during the titration
presumably due to a changing headgroup conformation during the
titration. Signiﬁcantly it shifts in the direction such that under
physiological conditions it maximizes the pool of protons available to
the membrane during proton pumping in oxidative phosphorylation.
Note that the conformation of the headgroup in Fig. 2 is
remarkably small especially given that CL has four chains. In Fig. 3
(left) the headgroup surface is hydrophobic with the phosphates
tucked under the bicyclic ring system. This may explain why pure CL
may form Hexagonal II phase complexes rather than bilayers.
This resonance-stabilized bicyclic headgroup may also explain the
recent ﬁnding that there is an unexpected symmetry in the lengths of
CL’s 4 fatty acid chains [33–35] in biological membranes. The bicyclic
Fig. 1. Titration curve of cardiolipin in bilayers. Saturated beef heart cardiolipin (CL)
bilayers potentiometrically titrated (red) along with its analogue missing the –OH
(dCL) (yellow). CL displays two pK’s at 4.0 and ∼8.0. The dCL displays two pK’s below
4.0. This can only be explained if the headgroup of CL contains two high energy H-bonds
formed by the two phosphates with the free hydroxyl of the glycerol.
Fig. 2. The resonance-stabilized structure of CL headgroup when it is in a bilayer. The
two phosphates of the headgroup can maintain this structure only when one of the
headgroup phosphates picks up a proton from water to H-bond with the pair of
electrons on the free –OH. Under these circumstances the single electron is dispersed
across the headgroup. In a bilayer at neutral pH, the headgroup has a single charge and
the pK of the headgroup is above that. (Appreciation is expressed to Dr. Michael
Schlame for contributing of the upper ﬁgure.)
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to stabilize the 2 H-bonds. An imbalance in the length of the pair of
chains on the two sides of the headgroup may disrupt the resonance
structure in Fig. 2 as shown in an exaggerated form in Fig. 3 (right).
Prokaryotes commonly have 16 carbon chains throughout their
phospholipid structures but eukaryotes do not. For any prokaryote,
four C16 lipid chains will symmetrically stabilize the CL headgroup
conformation in Fig. 2. Prokaryotes lack polyunsaturated fatty acid
chains. In contrast to the prokaryotes, the polyunsaturation of chains
in eukaryotes complicates the “length” estimates of the chains. In the
mammalian heart mitochondria, CL’s 4 chains are commonly
polyunsaturated linoleic acid esters, which solves the length problem.
The bicyclic structure allows the application of the high pK2 to
membrane surfaces that contain CL since the ring system would open
if the 2 chains on one side of the lipid would be shorter than the pair
on the other side as shown in Fig. 3.
Typical bacterial biosynthesis of CL’s headgroup involves an
enzyme belonging to the phospholipase D superfamily known as CL
synthase (Cls). It catalyzes a reversible phosphatidyl group transfer
from one phosphatidylglycerol (PG) molecule to another PG forming
CL and glycerol [4]. This enzyme appears to have a conserved N-
terminal segment for insertion into the prokaryote membrane [29]. In
contrast, in the eukaryotemitochondrion, the Cls is of the CDP-alcohol
phosphatidyltransferase superfamily using cytidine diphosphate-
diacylglycerol (CDP-DAG) as the donor of the phosphatidyl group
which is transferred to a the PG to form CL. In a surprising contrast it
appears that actinomycetes use the eukaryote biosynthetic system
[36]. This paper reviews the recent literature on the eukaryote–
prokaryote biosynthetic pathways.
2. Cardiolipin, its organization and role in ATP synthesis
CL is the only phospholipid in eukaryotes that is not synthesized
on the cytosolic face of the endoplasmic reticulum. It is synthesized in
the mitochondrion and usually remains there until cell death or
apoptosis [25,37,38]. Cardiolipin’s intimacy with the F0F1 ATP
synthase together with its high headgroup pK suggests it serves as a
proton source for protons used in proton-pumping during ATP
synthesis. When the headgroup has a pK in the range of 7 or 8 it is50% protonated; at 50% protonation little energy is needed to take or
deposit protons at each bilayer surface. Protons are rapidly supplied or
replaced at the surface by thewater. In this unique circumstance there
is no ΔpH across the bilayer. The removal of a proton from a bilayer
surface means that the energy is immediately converted into ΔΨ, the
membrane potential. Calculations by Junge [39] and by Oster [40]
have shown that the proton movement along F0 during the synthesis
of ATP is actually driven by ΔΨ and not by ΔpH. This is important, for
much of the transport activity in the mitochondrial inner membrane
occurs through transporters that are responsive to a membrane
potential. CL provides a high concentration of protons in the
headgroup surface on both sides, effectively removes the ΔpH as a
component of the energy in the ΔμH+.
A second way in which the high pK2 can facilitate ATP synthesis is
by neutralizing negative charge during electron transport on the C-
side of the membranes, say from a charged Coenzyme Q. The
neutralization of a proton on the C-side of the membrane would
create ΔΨ energy for proton pumping as computed by Oster [40] and
Junge [39]. Therefore simply neutralizing a cardiolipin proton on the
C-side of the mitochondrial membrane is equivalent to pumping a
proton across the membrane.
Another important role for cardiolipin in energy metabolism is to
anchor two very large kinases, mitochondrial creatine kinase (MtCK)
and nucleoside diphosphate kinase (NDPK-D) [25]. The two kinases
bind to CL on the inner and probably the outer mitochondrial
Fig. 3. Two structures of CL demonstrate the disruptive effect of a disparity in the “length” of the fatty acid chains of the lipid on the headgroup’s resonance structure. The four chains
on the left maintain the headgroup resonance. Lyso-cardiolipin (lysoCL) on the right cannot support the balance required to maintain the resonance. Its pK2 is below 4.0, as is that of
dCL which lacks the central OH-group that stabilizes the bicyclic headgroup stability (R. F. Epand, R. M. Epand and T. H. Haines unpublished). If the high pK2 of CL is important for the
synthesis of ATP [31] then the cleavage of a chain from CL to form lysoCL would hinder ATP synthesis in vivo.
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appear to provide channels for substrates, such as creatine phosphate,
between the matrix and the cytosol. The kinases share important
functional/structural analogies and roles in the bioenergetics of
mitochondria. Creatine kinase (MtCK) and by analogy dinucleotide
kinase NDPK-D are both oligomeric complexes. A quantitative
analysis of the properties of MtCK, in comparison with the X-ray
structure, shows the attachments with CL [41]. These proteins have
many isozymes, presumably characteristic of speciﬁc tissues. In
muscle and brain, for example, creatine kinase provides a reserve
supply of high energy phosphate (creatine phosphate) during initial
signal periods when the ATP is rapidly consumed. The cell needs an
instant source of ATP when glycolysis begins. Creatine phosphate is
used to phosphorylate the ADP rapidly until glycolysis establishes the
appropriate ATP concentration (2 to 7 seconds).
The evidence that these kinases are intimate with the bioenerget-
ics of the mitochondrion itself is clear because they bind to VDAC and
the ATP/ADP exchange protein. An extensive review by the Schattner
and Epand groups, major researchers in this ﬁeld, details some
unifying pathways for the operation of these proteins in energy
metabolism.
Cardiolipin also affects ATP synthesis by organizing proteins and
lipids in those membranes that make ATP. An exhaustive and
masterful application of physical techniques has helped our under-
standing of the organization and properties of CL-containing lipid
bilayers is provided by Lewis and McElhaney [28]. Their data bring
cardiolipin up to the standard of our understanding of the more
familiar double-chain lipids. On the other hand bilayers are static by
their nature whereas biological membranes are not.Cardiolipins in membranes, especially in the inner membrane of
mitochondria and in bacteria are very dynamic as shown by
Mileykovskaya and Dowhan [26]. Here the dynamism relates to the
exchanges of the lipid components of the multiprotein complexes
involved in diverse cellular functions including cell division, energy
metabolism and membrane transport. Examining the cardiolipin
deacylation/transacylation enzymes Schlame and Ren [27] propose a
dynamic structural homeostasis in the inner membrane of the
mitochondrion. It is based on the dynamics of the transfer of the
chains of the CL.
The regulation of the biosynthesis and degradation of cardiolipin
can be a response of osmotic activity in bacteria as shown in the
elegant experiments of Romantsov and Wood [21]. The response of
bacteria to osmotic induction of the gene encoding CL synthase which
alters the proportion of CL in membranes.
Most knownmitochondrial carrier proteins bind CL [23,24,42]. The
isolation and puriﬁcation of these proteins is often facilitated by the
addition of CL during their preparation. Since CL may convert the ΔpH
to the ΔΨ, the effect of ΔΨ on the transport activity and function
might proﬁtably be explored. This applies to all carriers that bind
cardiolipin including the transmembrane proteins dicarboxylate [43],
tricarboxylate [44], and uncoupling proteins [45]. For the latter, CL
also seems to regulate aspects of the uncoupling protein's activity
including nucleotide binding.
Each of the sixmitochondrial innermembrane proteins engaged in
ATP synthesis via its proton gradient displays high binding afﬁnity for
CL. This includes the ATP/ADP exchange protein [42,46], the F0,F1 ATP
synthase [47], the phosphate uptake protein [48–50], cytochrome
oxidase [51], the b,c1 complex [52,53], and NADH dehydrogenase
2000 Editorial[54,55]. There appears to be no evidence for the binding of CL to
succinate dehydrogenase, an enzyme that participates in oxidative
phosphorylation but not in the proton-gradient during ATP synthesis.
CL is largely in membranes that contain the F0F1 ATP synthase,
however the chloroplast thylakoid membrane lacks CL; it contains a
different ATP synthase (CF0CF1). It does, however, contain a unique
lipid, the plant sulfonolipid, (sulfonoquinovosyl diacylglyceride) that
can potentially serve a similar role since it always occurs in the
speciﬁc chloroplast membrane that contains CF0CF1. In some Gram-
positive cocci the sulfonolipid replaces cardiolipin and phosphatidyl
glycerol [56]. When prokaryote facultative anaerobes are denied
oxygen both the F0F1 ATP synthase and the CL disappear together.
3. Barth’s syndrome
The recognition that Barth’s Syndrome (BTHS) [11] is caused by a
mutation resulting in the remodeling of CL's chains [57,58] motivated
researchers to investigate them. The Schlame group examined CL’s
chains in natural membranes. They noted that the four chains are
symmetrical in length and in some cases like mammalian liver
mitochondria, identical [35]. These data indicate that the chains are
capable, in vivo, of maintaining the headgroup conformation shown in
Fig. 2. Were they not symmetrical, the bicyclic resonance-stabilized
headgroup shown in Fig. 3 for lyso-CL would collapse.
This work [35] involved the development of a yeast system that
mimicked the human defective taffazin CL chain array, which included
small quantities of lyso-CL. Vaz et al. [59] took advantage of this
observation to develop a simple assay for BTHS. Using HPLC-tandem
mass spectrometry they were able to identify BTHS in infants by
locating lyso-CL in blood spots. The presence of lyso-CL suggests that
the defective transacylase of BTHS may both lower the pK2 of the CL’s
and also reduce ATP synthesis. Major clinical features of the patients of
BTHS are myopathy, (weakness) and often cardiomyopathy, neutro-
penia and growth delay. All are accountable in cells that lack energy.
This combinedwith the location of CL among proteins involved in ATP
synthesis suggests ATP deﬁciency in a variety of organs. Whatever the
role of CL, the manner in which the chains are placed on CL in various
systems remains unclear. The combination of chains found on
symmetrical CL in eukaryote systems results from both from direct
biosynthesis and subsequent remodeling [60]. This requires two or
more enzymes which vary from yeast to fruitﬂy to mouse to human. A
recent review describes the manner in which these processes occur in
yeast as determined via knock-out genes [60].
Heart mitochondrial monolysocardiolipin acyltransferase is an
enzyme that models CL by its choice of fatty acids. The function of
this enzyme may be altered by alcohol, resulting in fetal alcohol
syndrome [61]. A number of recent studies have unraveled much of
the transacylation mechanisms of cardiolipin transacylation
[33,34,62,63], comparing them to similar transacylases of inositides
[64]. This work has allowed richer insights into the tafazzin gene
product that is defective in BTHS [10,35]. Another inference on chain
selection during the synthesis of CL in the mitochondrion is the
uptake of fatty acids. A major enzyme that regulates the fatty acid
uptake is the human fatty acid transport protein 1 (FATP-1) [65].
4. Apoptosis
For a cell in a multicellular organism to commit suicide for the
beneﬁt of the whole organism, it must ﬁrst destroy the energy source
of the cell—themitochondrion [20,66]. If so onewould expect a critical
target that is unique to mitochondria. Cardiolipin, rarely found
elsewhere in the cell, is the target of choice. CL is also present at the
contact sites between the outer and inner membranes; this CL is the
target of the tBid protein that approaches the mitochondrion with the
suicide message, possibly as a result of changes in the intrinsic
curvature of the membrane [67]. This ﬁrst step is followed by thebinding of CL to Bax/Bak, provoking oligomerization and cristae
remodeling that begins the destruction of the organelle.
Cardiolipin in mammalian mitochondria typically have 4 polyun-
saturated linoleic acid chains which are subject to oxidation. This
oxidation leads to “reactive oxygen species” (ROS), which in turn
releases cytochrome c (cyt c), an important water-soluble very basic
protein in the intermembrane space (IMS) and ultimately to the
cytosol.
CL binds to cyt c in a surprising manner; cyt c binds one of CL’s
chains with the other 3 chains embedded in themembrane. This “lipid
anchor” arrangement is made possible by a hydrophobic pocket in the
protein [68,69]. This unique binding alters the redox potential of cyt c
so that it no longer picks up electrons from the bc1 complex to reduce
cytochrome oxidase. This necessarily cuts off ATP synthesis. The
details on the relationship of CL and ROS have not yet become clear.
The ROS structure and details of its oxidation state(s) will play amajor
part of the apoptosis story as it unravels.
5. Coda
Finally, in contrast to commercial E. coli CL, commercial beef heart
CL does not easily form bilayers. It has four linoleic (polyunsaturated)
chains, which spread laterally in a bilayer, thinning the bilayer. Taken
together with its very small bilayer headgroup conformation (Fig. 2)
this presents as a concave surface. It tends to form hexagonal II (HII)
phase rather than a bilayer. For this reason the commercially available
E. coli CL preparation with its C16 chains, with only some mono-
unsaturates, formsmore stable bilayers. Such stable bilayer properties
may actually facilitate CL’s usefulness for E. coli in the initiation of
DNA replication [70].
A student today will ﬁnd cardiolipin interesting beyond the dull
textbook structure of 20 years ago. We have yet to recognize its role in
ATP synthesis, why and how its chains have length requirements (no
other phospholipids do), whether or not it forms rafts in membranes
sequestering membrane proteins, how it is an initiator in DNA
synthesis in E. coli as Crooke and Kornberg found, how osmotic effects
regulate it, and the details of how it works in apoptosis. There is still
too much mystery in it.
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